Form EFFECT KAZIA THERAPEUTICS LTD

December 3, 2024 6:04 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 2, 2024
Accession Number: 0001193125-24-267204
Submission Type: POS AM
CIK: 0001075880
Company Name: KAZIA THERAPEUTICS LTD
File Number: 333-276774


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings